Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07569341
What this trial is testing

Validation of the Classification for Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases

Who this might be right for
Colorectal Adenocarcinoma Metastatic in the Liver
University Hospital, Linkoeping 116
Early research (Phase 1)Ended earlyNCT02110953
What this trial is testing

Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver

Who this might be right for
Liver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+8 more
Fox Chase Cancer Center 2
Large-scale testing (Phase 3)Study completedNCT00020501
What this trial is testing

Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)UnknownNCT00506207
What this trial is testing

A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy

Who this might be right for
Colorectal NeoplasmGastric NeoplasmSecondary
National Cancer Center, Korea 23
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Testing effectiveness (Phase 2)Study completedNCT03890731
What this trial is testing

A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed

Who this might be right for
Solid Cancer
Bayer 6
Testing effectiveness (Phase 2)Ended earlyNCT01508000
What this trial is testing

Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases

Who this might be right for
Colorectal Cancer MetastaticLiver MetastasesKRAS Wild Type Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 44
Post-approval studies (Phase 4)Study completedNCT02567331
What this trial is testing

Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 28
Large-scale testing (Phase 3)Not Yet RecruitingNCT07025239
What this trial is testing

QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Qilu Pharmaceutical Co., Ltd. 430
Testing effectiveness (Phase 2)Looking for participantsNCT07728019
What this trial is testing

Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM

Who this might be right for
CRC (Colorectal Cancer)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Study completedNCT01909830
What this trial is testing

Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer Metastatic
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 18
Large-scale testing (Phase 3)Study completedNCT01607957
What this trial is testing

Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies

Who this might be right for
Colorectal Cancer
Taiho Oncology, Inc. 800
Early research (Phase 1)Study completedNCT00967577
What this trial is testing

177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors

Who this might be right for
Kidney CancerHead and Neck CancerBreast Cancer+6 more
Weill Medical College of Cornell University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06589830
What this trial is testing

TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticAdvanced Colorectal Cancer
Suzhou Teligene Ltd. 80
Testing effectiveness (Phase 2)WithdrawnNCT03764137
What this trial is testing

Imaging with [89Zr]Panitumumab-PET/MRI in Patients with Newly Diagnosed Colorectal Cancer

Who this might be right for
Metastatic Colon Cancer
University of Alabama at Birmingham
Not applicableStudy completedNCT02751177
What this trial is testing

Detection of KRAS, NRAS et BRAF Mutations in Plasma Circulating DNA From Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Institut de Cancérologie de Lorraine 236
Large-scale testing (Phase 3)Looking for participantsNCT07549412
What this trial is testing

Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

Who this might be right for
Metastatic Colorectal Cancer
EMD Serono Research & Development Institute, Inc. 1,020
Early research (Phase 1)Study completedNCT00648102
What this trial is testing

Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer

Who this might be right for
Breast CancerColorectal CancerPancreatic Cancer+2 more
Celldex Therapeutics 36
Not applicableLooking for participantsNCT07392567
What this trial is testing

Prospective Validation of an AI Model for Predicting Liver Metastasis in Colorectal Cancer

Who this might be right for
Colorectal Cancer Liver Metastasis
Tongji Hospital 160
Large-scale testing (Phase 3)Looking for participantsNCT04516681
What this trial is testing

Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerVitamin CGLUT3
Fudan University 400
Next Page